Want to see GB:IOF full AI Analyst Report?
IOF Stock Chart & Stats
58.00 p
1.00 p(1.72%)
At close: 4:00 PM EDT
58.00 p
1.00 p(1.72%)
Day’s Range― - ―
52-Week Range20.00 p - 60.12 p
Previous CloseN/A
Volume50.80K
Average Volume (3M)188.59K
Market Cap
£100.73M
Enterprise Value122.57M
Total Cash (Recent Filing)£11.74M
Total Debt (Recent Filing)£6.66M
Price to Earnings (P/E)17.4
Beta0.30
Next Earnings
Sep 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding191,858,400
10 Day Avg. Volume227,450
30 Day Avg. Volume188,590
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)1.22
Price to Sales (P/S)1.00
P/FCF Ratio26.63
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£65.00Price Target Upside12.07% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.04
Revenue Forecast (FY)£70.40M
Bulls Say, Bears Say
Bulls Say
Production Scale-upProduction has expanded substantially, demonstrating operating capability and growing scale. The IO#11 and Permian projects provide visible capacity additions that can increase iodine volumes and spread fixed costs over a larger output base.
Conservative Balance SheetLow leverage and expanding equity provide financial flexibility to fund operations and selective expansion. Although debt increased in 2025, it remains modest relative to assets and equity, reducing balance-sheet risk during growth investment.
Revenue And EBITDA GrowthHigher iodine volumes and realized prices are translating into strong top-line and EBITDA growth. This indicates demand remains supportive and that the company can convert increased production into improved earnings while plant costs remain controlled.
Bears Say
High Expansion Funding NeedsThe accelerated build-out requires substantial capital relative to the company’s current scale. Greater reliance on debt increases execution and financing risk if plant commissioning is delayed, iodine prices weaken, or returns fall below project assumptions.
Weak Free-cash-flow ConversionHealthy operating cash generation has not consistently translated into free cash flow because of capital spending and working-capital movements. This may constrain internally funded expansion and increase dependence on facilities or timing of collections.
Customer Concentration RiskA concentrated customer base can make revenue, pricing, and receivables more sensitive to individual customer decisions. Losing or weakening a major account could reduce utilization and cash generation while the company is investing in new capacity.
Iofina plc News
IOF FAQ
What was Iofina PLC’s price range in the past 12 months?
Iofina PLC lowest share price was 20.00 p and its highest was 60.12 p in the past 12 months.
What is Iofina PLC’s market cap?
Iofina PLC’s market cap is £100.73M.
When is Iofina PLC’s upcoming earnings report date?
Iofina PLC’s upcoming earnings report date is Sep 18, 2026 which is in 28 days.
How were Iofina PLC’s earnings last quarter?
Iofina PLC released its earnings results on Apr 30, 2026. The company reported 0.021 p earnings per share for the quarter, beating the consensus estimate of N/A by 0.021 p.
Is Iofina PLC overvalued?
According to Wall Street analysts Iofina PLC’s price is currently Undervalued.
Does Iofina PLC pay dividends?
Iofina PLC does not currently pay dividends.
What is Iofina PLC’s EPS estimate?
Iofina PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Iofina PLC have?
Iofina PLC has 191,858,400 shares outstanding.
What happened to Iofina PLC’s price movement after its last earnings report?
Iofina PLC reported an EPS of 0.021 p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 20%.
Which hedge fund is a major shareholder of Iofina PLC?
Currently, no hedge funds are holding shares in GB:IOF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Iofina plc Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
£65.00 (12.07% Upside)
£65.00 (12.07% Upside)
Insider Transactions
Bought Shares
Worth £10.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
27.63%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
15.62%
Trailing 12-Months
Company Description
Iofina PLC
Iofina plc, together with its subsidiaries, explores for, develops, and produces iodine and halogen-based specialty chemical derivatives from oil and gas operations in North America, Asia, South America, Europe, and internationally. The company offers iodides, chlorides, and fluorides; and iodine used for animal care and health, biocides and catalysts, disinfectants, fungicide, specialty intermediates, mineral separators, thyroid health, wound healing, diagnostic imaging, iofina logo gray sun 5, preservatives and sanitizers, semiconductor etchant gas, soil fumigants, fine halogen chemicals, electronic specialty gases, and heat stabilizers applications. The company markets its products in electronics/semiconductor, pharmaceutical, food and beverage, personal care, paints and coatings, dairy, chemical intermediates, gemological, fish and wildlife, nylon, x-ray contrast media industries. It serves animal nutrition, biocidal paints and coatings, disinfectants, x-ray contrast media, pharmaceuticals, electronics, perovskites for solar, optical polarizing films, industrial, oil and gas industries. The company sells its products under the IOflo and IOprill brand names. Iofina plc was incorporated in 2005 and is based in London, the United Kingdom.
IOF Stock 12 Month Forecast
Average Price Target
65.00 p
▲(12.07% Upside)